Fisher & Paykel Healthcare Corporation Limited (AU:FPH)
ASX:FPH
FPH Stock Chart & Stats
AU$31.23
AU$0.04(0.12%)
At close: 4:00 PM EST
AU$31.23
AU$0.04(0.12%)
Day’s Range― - ―
52-Week RangeAU$26.51 - AU$35.31
Previous CloseN/A
Volume151.81K
Average Volume (3M)485.38K
Market Cap
AU$17.91B
Enterprise ValueAU$21.59B
Total Cash (Recent Filing)AU$461.10M
Total Debt (Recent Filing)AU$146.10M
Price to Earnings (P/E)46.6
Beta0.73
Next Earnings
Dec 02, 2026EPS Estimate
0.34Next Dividend Ex-DateN/A
Dividend Yield1.92%
Share Statistics
EPS (TTM)0.80
Shares Outstanding587,289,000
10 Day Avg. Volume621,556
30 Day Avg. Volume485,379
Financial Highlights & Ratios
PEG Ratio1.32
Price to Book (P/B)10.37
Price to Sales (P/S)9.38
P/FCF Ratio44.75
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$35.13Price Target Upside12.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
EPS Forecast (FY)0.77
Revenue Forecast (FY)AU$2.11B
Fisher & Paykel Healthcare Corporation Limited News
FPH FAQ
What was Fisher & Paykel Healthcare Corporation Limited’s price range in the past 12 months?
Fisher & Paykel Healthcare Corporation Limited lowest share price was AU$26.51 and its highest was AU$35.31 in the past 12 months.
What is Fisher & Paykel Healthcare Corporation Limited’s market cap?
Fisher & Paykel Healthcare Corporation Limited’s market cap is AU$17.91B.
When is Fisher & Paykel Healthcare Corporation Limited’s upcoming earnings report date?
Fisher & Paykel Healthcare Corporation Limited’s upcoming earnings report date is Dec 02, 2026 which is in 178 days.
How were Fisher & Paykel Healthcare Corporation Limited’s earnings last quarter?
Fisher & Paykel Healthcare Corporation Limited released its earnings results on May 25, 2026. The company reported AU$0.353 earnings per share for the quarter, beating the consensus estimate of AU$0.352 by <AU$0.001.
Is Fisher & Paykel Healthcare Corporation Limited overvalued?
According to Wall Street analysts Fisher & Paykel Healthcare Corporation Limited’s price is currently Undervalued.
Does Fisher & Paykel Healthcare Corporation Limited pay dividends?
Fisher & Paykel Healthcare Corporation Limited pays a Notavailable dividend of AU$0.196 which represents an annual dividend yield of 1.92%. See more information on Fisher & Paykel Healthcare Corporation Limited dividends here
What is Fisher & Paykel Healthcare Corporation Limited’s EPS estimate?
Fisher & Paykel Healthcare Corporation Limited’s EPS estimate is 0.34.
How many shares outstanding does Fisher & Paykel Healthcare Corporation Limited have?
Fisher & Paykel Healthcare Corporation Limited has 587,289,000 shares outstanding.
What happened to Fisher & Paykel Healthcare Corporation Limited’s price movement after its last earnings report?
Fisher & Paykel Healthcare Corporation Limited reported an EPS of AU$0.353 in its last earnings report, beating expectations of AU$0.352. Following the earnings report the stock price went up 9.154%.
Which hedge fund is a major shareholder of Fisher & Paykel Healthcare Corporation Limited?
Currently, no hedge funds are holding shares in AU:FPH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
FPH Company Deck
FPH Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call conveyed a predominantly positive operational and financial performance: strong top-line growth, substantial NPAT expansion, margin improvement, robust cash flow, higher dividends and continued investment in capacity and R&D. The company provided constructive FY'27 guidance but also clearly articulated material near-term headwinds — notably U.S. tariffs, surcharges from the Middle East conflict, FX/hedging losses, and the risk of hardware growth normalizing after an exceptional year. Management stressed that continuous improvement and manufacturing/network flexibility should offset many of these pressures, but several macro and policy risks remain.View all AU:FPH earnings summariesFPH Stock 12 Month Forecast
Average Price Target
AU$35.13
▲(12.48% Upside)
Technical Analysis
EBOS Group Limited
―
Pacific Edge Limited
―
Ryman Healthcare
―
TruScreen Group Ltd.
―
AFT Pharmaceuticals Ltd.
―
Options Prices
Currently, No data available
---